Development for and clinical trials of molecular targeting drugs
Takashima, A.; Fukuda, H.; Shibata, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
2010
ISSN/ISBN: 0385-0684 PMID: 20524257 Document Number: 639947
Document emailed within 1 workday
Related Documents
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826Tang, Q.; Ding, Q.; Lin, L.; Zhang, Z.-z.; Dai, Z.; Zhan, J.-b. 2012: Development of antibody drugs targeting against HER2 for cancer therapy Yao Xue Xue Bao 47(10): 1297-1305
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Bergqvist, D. 1992: Review of clinical trials of low molecular weight heparins European Journal of Surgery 158(2): 67-78
Demetter, P.; Maréchal, R.; Verset, L.; Salmon, I.; Bachet, J.-B.; Van Laethem, J.L. 2012: Molecular changes in pancreatic cancer: implications for molecular targeting therapy Acta Gastro-Enterologica Belgica 75(2): 210-214
Lal, A.; Sharma, M.L. 1992: An assessment of clinical trials with drugs Indian Journal of Physiology and Pharmacology 36(2): 143-145
Tabe, Y. 2009: Molecular diagnosis of and molecular targeting therapy for leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 57(2): 137-145
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Elliott, G.A. 1970: The impact of clinical trials of drugs on the investigator, the industry and the country South African Medical Journal 44(1): 5-7
Plat, F. 1992: Methodology of phase Ii clinical trials of hypocholesteremic drugs: which criteria? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 2): 117-120
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Bartus, R.T.; Dean, R.L.; Beer, B. 1983: An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans Psychopharmacology Bulletin 19(2): 168-184
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69